Cardiovascular evaluation of patients undergoing cancer treatment at a clinic for childhood cancer survivors in Mexico

被引:0
作者
Jimenez-Carbajal, Maria G. [1 ]
Antunez-Sanchez, Sandra P. [2 ]
Arreguin-Gonzalez, Farina E. [3 ]
Benito-Resendiz, Alma E. [4 ]
机构
[1] Ctr Med ABC, Dept Cardiol, Mexico City, DF, Mexico
[2] Ctr Med Nacl 20 Noviembre, Dept Pediat Echocardiog, Mexico City, DF, Mexico
[3] Ctr Med Nacl 20 Noviembre, Dept Pediat Oncol, Mexico City, DF, Mexico
[4] Ctr Med Nacl 20 Noviembre, Childhood Canc Survivors Clin, Mexico City, DF, Mexico
来源
ARCHIVOS DE CARDIOLOGIA DE MEXICO | 2021年 / 91卷 / 01期
关键词
Cardiovascular evaluation; Childhood cancer; Survivors; Strain; CARDIO-ONCOLOGY; HEART-FAILURE; LONG-TERM; CARDIOTOXICITY; ECHOCARDIOGRAPHY; MORTALITY; CHILDREN; THERAPY; STRAIN; PAPER;
D O I
10.24875/ACME.M21000173
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The objective of the study was to describe the cardiovascular effects of childhood cancer treatment in survivors through clinical, electrocardiogram, and echocardiographic methods. Materials and methods: Prospective, observational case-control study of 34 patients of a Childhood Cancer Survivors Clinic, evaluated clinically, with electrocardiogram, with conventional echocardiography and strain. Average age 13.03 years; the average cumulative dose of anthracyclics was 219.5 mg/m2; seven patients also received chest radiation. The analysis was done with Student's T-tests and linear regression. Results: Left ejection fraction (EF) in survivors was preserved. Longitudinal left strain in two, three chambers, and circumferential was decreased in survivors (p < 0.05). Those undergoing radiotherapy and anthracyclic presented increased heart rate, EF, left shortening fraction decreased (< 0.05), and right ventricle without significant changes. Discussion and conclusions: There are a large number of childhood cancer survivors treated with cardiotoxics and radiotherapy. They may present changes in ventricular myocardial strain (even with normal EF) and/or arrhythmias, as evidenced in the group studied, which is consistent with the previous international studies. Its complete cardiovascular evaluation is important to predict the risk of heart failure as part of a protocolized follow-up in well-established cardio oncology clinics.
引用
收藏
页码:24 / 32
页数:9
相关论文
共 25 条
[1]   Cardiotoxicity associated with cancer therapy: Pathophysiology and prevention strategies [J].
Adao, Rui ;
de Keulenaer, Gilles ;
Leite-Moreira, Adelino ;
Bras-Silva, Carmen .
REVISTA PORTUGUESA DE CARDIOLOGIA, 2013, 32 (05) :395-409
[2]   Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention [J].
Albini, Adriana ;
Pennesi, Giuseppina ;
Donatelli, Francesco ;
Cammarota, Rosaria ;
De Flora, Silvio ;
Noonan, Douglas M. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (01) :14-25
[3]   Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography [J].
Cetin, Sueha ;
Babaoglu, Kadir ;
Basar, Evic Z. ;
Deveci, Murat ;
Corapcioglu, Funda .
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2018, 35 (02) :234-240
[4]   Preventing and Treating Anthracycline-Related Cardiotoxicity in Survivors of Childhood Cancer [J].
Diamond, Melissa B. ;
Franco, Vivian I. ;
Miller, Tracie L. ;
Lipshultz, Steven E. .
CURRENT CANCER THERAPY REVIEWS, 2012, 8 (02) :141-151
[5]   Educational Paper: Decreasing the burden of cardiovascular disease in childhood cancer survivors: An update for the pediatrician [J].
Dillenburg, Rejane F. ;
Nathan, Paul ;
Mertens, Luc .
EUROPEAN JOURNAL OF PEDIATRICS, 2013, 172 (09) :1149-1160
[6]   Type II chemotherapy-related cardiac dysfunction: Time to recognize a new entity [J].
Ewer, MS ;
Lippman, SM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) :2900-2902
[7]  
Florescu Maria, 2013, Maedica (Bucur), V8, P59
[8]  
Gallegos CS, 2009, GAMO, V8, P35
[9]   Frequency and risk factors of anthracycline-induced clinical heart failure in children:: a systematic review [J].
Kremer, LCM ;
van Dalen, EC ;
Offringa, M ;
Voûte, PA .
ANNALS OF ONCOLOGY, 2002, 13 (04) :503-512
[10]   LATE CARDIAC EFFECTS OF DOXORUBICIN THERAPY FOR ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDHOOD [J].
LIPSHULTZ, SE ;
COLAN, SD ;
GELBER, RD ;
PEREZATAYDE, AR ;
SALLAN, SE ;
SANDERS, SP .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) :808-815